• Postgraduate Year Four, Cardiac Surgery, University of Toronto (2014 - Present)
• Doctor of Philosophy, Health Technology Assessment, Institute for Health Policy, Management, and Evaluation, University of Toronto, Health Services Research Program (2016-2020), PhD
• Doctor of Medicine, Queen’s University (2010 - 2014), MD
• Honours Bachelor of Science, Pharmacology and Toxicology, University of Toronto (2005 - 2010), BSc

Clinical Interests

- Aortic valve surgery

- Minimally invasive cardiac surgery

- Structural heart interventions

- Conduits in coronary surgery

Research Interests

Derrick’s doctoral research on trends and outcomes in aortic valve replacement in the era of transcatheter aortic valve replacement, utilizing large administrate databases from the United States (STS National Database) and those in Canada (Institute for Clinical and Evaluative Sciences). He has an interest in statistical methods and a strong focus on decision analysis modeling and cost-effectiveness modeling. He hopes his research will impact clinical decision making at both the patient level and at the policy level.

Canadian Cardiovascular Society – C3I, COVID-19 Research Challenge Grant 2020

Dr. Paul Cartier Resident Research Award, Canadian Cardiovascular Congress 2019, Montreal, Canada

Canadian Institutes for Health Research (CIHR) Fellowship Award (2018 - 2021)

Paul C. Samson Resident Essay Prize, The Western Thoracic Surgical Association, 43rd Annual Meeting, Colorado Springs, Colorado. 

Sunnybrook Education Advisory Council (SEAC) 2017 Education Research and Scholarship Grant, Sunnybrook Health Sciences Centre, Toronto, Canada,

Bayer Vascular Award, Resident Research Competition, Canadian Cardiovascular Congress, October 2016

Health Services Research Award, Resident Competition, Physicians’ Services Incorporated Foundation, Ontario, October 2015

Full publication list available on PubMed:

https://pubmed.ncbi.nlm.nih.gov/?term=derrick+tam&sort=date

Tam DY, Wijeysundera HC, Naimark D, Gaudino M, Webb JG, Cohen DJ, Fremes SE. Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low Risk Patients with Severe Aortic Stenosis. Circulation. 2020;374:1609.

Tam DY, Dharma C, Rocha R, Farkouh ME, Abdel-Qadir H, Sun LY, Wijeysundera HC, Austin PC, Udell JA, Gaudino M, Fremes SE, Lee DS. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. J Am Coll Cardiol. 2020;76:1153–1164.

Tam DY, Dharma C, Rocha RV, Austin PC, Wijeysundera HC, Farkouh M, Gaudino M, Sadat S, Lee DS, Fremes SE. Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus. Circ Cardiovasc Interv. 2020;367:CIRCINTERVENTIONS120009082.

Tam DY, Dharma C, Rocha RV, Ouzounian M, Wijeysundera HC, Austin PC, Chikwe J, Gaudino M, Fremes SE. Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort. JACC Cardiovasc Interv. 2020;13:765–774.

Tam DY, Rocha RV, Fang J, Ouzounian M, Chikwe J, Lawton J, Ko DT, Austin PC, Gaudino M, Fremes SE. Multiple arterial coronary bypass grafting is associated with greater survival in women. Heart. 2020 Oct 20;378:heartjnl–2020–317737.

This email address is being protected from spambots. You need JavaScript enabled to view it.